State Street Corporation »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by State Street Corporation

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by State Street Corporation from 13F filings

Historical chart of State Street Corporation investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by State Street Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $24M 22M 1.08
2024-03-31 $21M 22M 0.94
2023-12-31 $23M 23M 0.99
2023-09-30 $22M 23M 0.93

More positions owned by State Street Corporation

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
UnitedHealth (UNH)
Tesla Motors (TSLA)

View all positions for State Street Corporation

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Deerfield Management Company
Aequim Alternative Investments
Lazard Asset Management
BlackRock
Davidson Kempner Capital Management
Calamos Advisors
Invesco
BlackRock
State Street Corporation
Morgan Stanley
MacKay Shields
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1